Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04181840
Other study ID # 2/1/2019 (May 6)
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date October 15, 2019
Est. completion date July 20, 2020

Study information

Verified date September 2020
Source OASIS Diagnostics S.A.
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The main purpose of the study is to evaluate the effectiveness and safety of the impedance spectroscopy device prototype in the detection of anal sphincter injuries in women in the early postpartum period. The study is prospective. The study group comprises up to 56 patients; up to 16 weeks from a natural delivery. The planned participation of each patient in the study is up to 4 weeks and two visits will take place at that time.

After obtaining written consent, at the first visit (V1) each patient will undergo a physical examination (both proctological and gynecological examination), blood samples for laboratory tests and stool samples for calprotectin concentration assessment will be collected. The presence of clinical symptoms of both gas and stool incontinence will be assessed during the visit with the use of Wexner's scale. Then, the dates of two reference tests will be planned: Trans-rectal USG and Recto-anal manometry which will be performed as part of the V1 visit within a period not exceeding 27 days.

The V2 visit, which will also be the final visit, will include a reassessment of the patient's general condition, recording the values of basic vital parameters, subjective and physical examination, and then the doctor conducting the examination will finally determine the extent of sphincter damage, present the patient with therapeutic options and decide on the treatment or rehabilitation of sphincter.

During the visits, all adverse events will also be monitored, both those reported by patients and those related to the examined diagnostic device.


Recruitment information / eligibility

Status Completed
Enrollment 49
Est. completion date July 20, 2020
Est. primary completion date June 26, 2020
Accepts healthy volunteers No
Gender Female
Age group 18 Years to 49 Years
Eligibility Inclusion Criteria:

- women patients,

- 18-49 years old,

- up to 16 weeks from a natural delivery

- with the presence of:

1. clinically confirmed OASIS at least stage II, as a result of an episiotomy or uncontrolled crotch rupture (in patients with crotch protection), or

2. at least one risk factor, such as:

- the extended second delivery phase,

- instrumental delivery (vacuum or forceps),

- shoulder dystocia,

- birth weight of the child > 4kg,

- episiotomy,

- uncontrolled perineal laceration (in patients with crotch protection),

- induction of delivery using oxytocin,

- head circumference =34 mm and other.

- the patient's understanding of the nature of the clinical study and permission in writing from the patient to participate in this study.

Exclusion Criteria:

- the presence of acute diseases during treatment,

- the presence of chronic diseases not treated or treated insufficiently (e.g., incorrectly controlled hypertension),

- the presence of diseases with accompanying symptoms of fecal incontinence history of proctology surgery's whit postoperative complication,

- the presence of inflammatory bowel diseases during the exacerbation phase,

- the treatment in the last year because of serious, progressive, uncontrolled cardiological, pulmonary, nephrology, contagious or psychiatric illness whose course could affect the patient's risk increase due to participation in the study,

- significant disease symptoms so far undiagnosed,

- the presence or suspected malignant disease or previous on previous oncological treatment in the last 5 years,

- the presence of a cardiac stimulator or cardioverter-defibrillator,

- severe surgery or severe trauma in the last year.

Study Design


Intervention

Diagnostic Test:
Blood and faeces tests
During V1 - Laboratory tests, particularly for calprotectin concentration assessment
Device:
Impedance spectroscopy test
During V1 - the electrical impedance of anal sphincter muscles will be measured
Diagnostic Test:
Full gynecological and proctological examination
During V1 and V2 - Examination with a gynecological speculum, Two-handed examination, Rectal examination, and Anoscopy
Transanal ultrasonography
During V1 - reference diagnostic methods with documented effectiveness and safety; for comparison with impedance spectroscopy results.
Anorectal manometry
During V1 - reference diagnostic methods with documented effectiveness and safety; for comparison with impedance spectroscopy results.
Other:
Determining the degree of sphincter injury
During V2 - conducting the examination will finally determine the extent of sphincter damage, present the patient with therapeutic options and decide on the treatment or rehabilitation of sphincter.

Locations

Country Name City State
Poland Praktyka Lekarska Malgorzata Uchman-Musielak Warsaw Mazowieckie

Sponsors (1)

Lead Sponsor Collaborator
OASIS Diagnostics S.A.

Country where clinical trial is conducted

Poland, 

Outcome

Type Measure Description Time frame Safety issue
Primary Anal sphincters continuity (injuries) assessed in physical examination and trancanal ultrasonography Assessment using:
OASIS classification of perineal tears.
Starck scale (0-16 scale, no defect - 0, maximum - 16, which means severe damage of both sphincters on a considerable length and circumference).
Norderval scale (0-7 scale, no defect - 0, 7 is the maximal damage of both anal sphincters).
16 weeks
Primary Anal sphincter tension (function) assessed in physical examination and anorectal manometry 16 weeks
Primary Anal sphincter assessment evaluated by impedance spectroscopy Estimation of the presence, extent and severity of anal sphincter injury, by impedance moduli and phase shifts.
The main aim of the study is to establish whether the extension and severity of obstetric anal sphincter injury can be precisely assessed with parameters calculated from anal sphincter muscles using impedance spectroscopy.
16 weeks
Secondary Adverse events Evaluation of the frequency and intensity of adverse events associated with the use of the new diagnostic method. 16 weeks
See also
  Status Clinical Trial Phase
Recruiting NCT05935371 - Consequences of Obstetric Anal Sphincter Injuries on Maternal Psychology and Relationship Experience
Completed NCT06449872 - OB-GYN Clinical Validation Study N/A
Active, not recruiting NCT05354284 - Physical and Mental Health Among Sexual and Gender Minorities During Pregnancy, Birth and Postpartum
Active, not recruiting NCT04483986 - Does Rectus Re-approximation Cause Adhesion After Cesarean Section? N/A
Completed NCT04903977 - Detection of Obstetric Anal Sphincter Injuries With ONIRY Device N/A
Terminated NCT03478163 - Antibiotics During Intrauterine Balloon Tamponade Placement Phase 4
Not yet recruiting NCT06325319 - Effect of Community Engagement Using M-Mama Champions N/A
Recruiting NCT04664660 - Endometriosis and Obstetric Outcomes
Completed NCT03856307 - Reliability of Simple Sonographic Findings Acquired With Hand-held Apparatuses to Inform Obstetric Diagnosis
Recruiting NCT06273007 - Improving Intrapartum Care for Saving Life at Birth in Ethiopia Through PartoMa Approach N/A
Completed NCT03828630 - Lung Ultrasound to Detect Pulmonary Complications in Critically Ill Parturients
Completed NCT03161184 - Impact of a Smartphone Intervention on Tanzanian Women's Childbirth Location N/A
Completed NCT03653884 - Intra-abdominal Umbilical Vein Aneurysm
Completed NCT03522909 - The Center for Peripartum Optimization
Completed NCT05704179 - Evaluation of the Relationship Between Obstetric Comorbidity Index and Obstetric Quality of Recovery Score
Completed NCT05079139 - Musset's Surgical Technique: Evaluation of Long-term Results (LONGOMUSSET) N/A
Not yet recruiting NCT05307393 - Maternal Positioning to Correct Fetal Occiput Posterior N/A
Completed NCT04536753 - The Utility of Customised Growth Charts for Identifying Macrosomia and the Effect of Intervention
Completed NCT04852237 - Is the Lack of Prior Exposure to Sperm Antigens Associated With Worse Neonatal and Maternal Outcomes?
Completed NCT04894136 - Reproductive and Obstetric Outcomes in TESE-ICSI Cycles for Azoospermia

External Links